Carnegie acted as financial adviser to Medivir in respect of the redemption programme. Medivir is an emerging and profitable research based pharmaceutical company with an established marketing and sales organisation in the Nordic region with a broad portfolio of prescription pharmaceuticals. February 2015.
Healthcare
Redemption offer in Medivir (SE) — SEK 625 million
February 2015